Company Filing History:
Years Active: 2019-2022
Title: Innovations of Chris Netherton in Vaccine Development
Introduction
Chris Netherton is a notable inventor based in Woking, GB. He has made significant contributions to the field of vaccine development, particularly in relation to African Swine Fever (ASF). With a total of 2 patents, his work is crucial in addressing this serious viral disease affecting swine populations.
Latest Patents
Netherton's latest patents focus on an attenuated African Swine Fever virus vaccine. The first patent provides an attenuated ASF virus that lacks functional versions of specific genes, including the DP148R gene. This invention also details a vaccine comprising such an attenuated virus, aimed at preventing ASF. Additionally, it discusses the intranasal administration of the attenuated ASF virus. The second patent similarly outlines an attenuated ASF virus lacking functional versions of multigene-family 360 genes and the DP148R gene, further emphasizing the vaccine's potential in preventing ASF.
Career Highlights
Chris Netherton is associated with The Pirbright Institute, where he conducts his research and development work. His focus on ASF vaccines highlights his commitment to improving animal health and preventing disease outbreaks in swine.
Collaborations
Netherton collaborates with esteemed colleagues, including Charles Abrams and Ana-Luisa Reis. Their combined expertise contributes to the advancement of vaccine research and development.
Conclusion
Chris Netherton's innovative work in developing vaccines for African Swine Fever demonstrates his significant impact on veterinary medicine. His patents reflect a dedication to improving animal health and preventing disease outbreaks.